In neurons, defects in APP trafficking and processing leading to Aβ production are likely the most common cause of AD; thus, understanding how APP is targeted to a defined cellular compartment and identifying the mechanisms that control the Aβ generation, could be a key for new therapies [8,9]. The gene discussed is APP; the disease is Alzheimer disease.